Skip to content

ONI vs Refeyn

ONI logo

ONI

See protein, DNA and RNA molecules that make life work, in nanoparticles, viruses, bacteria, cells and tissue

210 employees · est. 2016 · Oxford, United Kingdom

VS
Refeyn logo

Refeyn

Accelerating discovery and revolutionizing single-molecule bioanalytics with mass photometry

166 employees · est. 2018 · Oxford, United Kingdom

ONI is the older company (2016 vs 2018); ONI is the larger of the two.

Side-by-Side Comparison

ONI Refeyn
Founded
2016 older 2018
Headquarters
Oxford, United Kingdom Oxford, United Kingdom
Employees
210 larger 166
Industry
Biotechnology, Life Sciences Biotechnology, Life Sciences, Pharmaceutical
Funding Stage
Series B Series A
Total Funding
$109.40M $30.00M
Funding Rounds
6 3
Services
High-resolution Imaging Solutions, Data Analysis and Visualization, Cloud-based Collaboration Platform, Sample Characterization Services, Microscopy Training and Support Mass Photometry Instruments, Technical Support, Application Notes and Webinars, Instrument Installation, Service Contracts
Target Customers
Research Scientists, Biotechnologists, Pharmaceutical Researchers, Microscopy Technicians, Academia and Research Institutions Biotech Companies, Pharmaceutical Companies, Academic Research Institutions, Contract Research Organizations (CROs), Contract Development and Manufacturing Organizations (CDMOs)
Taxonomy
Super-resolution MicroscopyFluorescence ImagingSingle-molecule ImagingLocalization MicroscopyNanotechnologyMolecular Research +8 Mass PhotometrySingle-molecule BioanalyticsMolecular AnalysisBiomolecular FunctionBiotherapeutic DevelopmentScientific Innovation +9
Website
oni.bio refeyn.com
ONI logo

About ONI

ONI, founded in 2016, is a pioneering company headquartered in the United Kingdom, operating at the intersection of Biotechnology and Life Sciences. Their core innovation is The Nanoimager, the world's first desktop compatible compact super-resolution microscope, designed to provide unprecedented vi...

Refeyn logo

About Refeyn

Refeyn is a transformative player in the Biotechnology and Life Sciences sectors, hailing from the United Kingdom. Founded in 2018, the company is at the forefront of molecular analysis through its pioneering mass photometry technology. This innovative approach offers a novel way of weighing individ...

Also comparing in this category

Comparing more than these two?

Get ONI, Refeyn and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does ONI compare?

A PDF of ONI and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

ONI was founded in 2016, based in Oxford, United Kingdom, with 210 employees. ONI, founded in 2016, is a pioneering company headquartered in the United Kingdom, operating at the intersection of Biotechnology and Life Sciences. Their core innovation is The Nanoimager, the world'. Refeyn was founded in 2018, based in Oxford, United Kingdom, with 166 employees. Refeyn is a transformative player in the Biotechnology and Life Sciences sectors, hailing from the United Kingdom. Founded in 2018, the company is at the forefront of molecular analysis through its pi.
ONI has raised $109.40M and Refeyn $30.00M. Latest stage: ONI Series B, Refeyn Series A.
Both work in Biotechnology and Life Sciences.

Compare ONI with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at ONI on 24 Mar 2026, and Refeyn on 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout